InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,419.20
(
0.00%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.52
(
0.47%
)
Bitcoin
64,320.16
(
0.50%
)
Post# of 14671
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

NoMoDo

Send PM Follow Ignore
Followers 148
Posts 7871
Boards Moderated 2
Alias Born 03/15/2002

NoMoDo

Member Level

Re: None

Wednesday, 01/29/2003 1:52:19 PM

Wednesday, January 29, 2003 1:52:19 PM

Post# of 14671
Federal Government Agency Requested Today an Urgent Meeting With IBCI to



RELATED SYMBOLS: (IBCL)

ATLANTA, Jan 29, 2003 /PRNewswire-FirstCall via COMTEX/ -- International
BioChemical Industries, Inc. (OTC Bulletin Board: IBCL) announced that a Federal
Government Agency has requested today an urgent meeting with the firm to discuss
the BioShield line of products in the war on bioterrorism.

According to the government official who contacted IBCI, the request is being
made after a review by his agency of the technical data publicly available from
the EPA.

In addition the company also announced discovery of a new proprietary use for
the technology discovered during testing at a major University lab. The facility
was engaged by IBCI's distributor, Nova BioGenetics, Inc., in order to fulfill a
request by a pharmaceutical firm to run tests on the product for a specific
disease.

About International BioChemical Industries:

International BioChemical Industries, Inc. is a Norcross, Georgia-based emerging
growth company focused on biotechnology and antimicrobial products. Its core
business is committed to the discovery, development, marketing and sale of
surface-modifying antimicrobial and biostatic products. The company's
antimicrobial technology is an alternative to conventional sanitizers,
disinfectants, bleaches, biocides or preservatives primarily because it kills
bacteria on contact and can remain active for extended time periods. To date
IBCI has received four U.S. patents and eight EPA registrations, including the
first U.S. germ killer and disinfectant against Salmonella cholerasuis,
Staphylococcus aureus and other microorganisms. The company has developed
several alliances in different industries, such as healthcare, textiles and
storm water.

Further information on IBCI and its line of products can be found by visiting
the firm's web site at http://www.bioshield.com , or by calling 1-770-925-3653,
Tim Moses.

Safe Harbor/Forward-looking Statements:

Statements in this news release that are not historical are forward- looking
statements. These forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from those
anticipated in any forward-looking statements, all of which are difficult to
predict and many of which are beyond the control of the company, including areas
such as: developing technologies; dependence on collaborative partners; the
inherent complexity and uncertainty regarding the development of products;
early-stage development of IBCI; the result of research and development efforts;
future capital needs; uncertainty of additional funding; government regulations;
and other factors which are detailed in the company's periodic reports and
registration statements filed with the Securities and Exchange Commission. IBCI
does not undertake to revise or update any forward- looking statement to reflect
events or circumstances that may arise after the date hereof. BioShield is a
trademark of IBCI.

SOURCE International BioChemical Industries, Inc.


CONTACT: Tim Moses of International BioChemical Industries,
+1-770-925-3653

URL: http://www.bioshield.com
http://www.prnewswire.com

Copyright (C) 2003 PR Newswire. All rights reserved.

-0-


KEYWORD: Georgia
District of Columbia
INDUSTRY KEYWORD: CHM
OTC

(Wall Street)



Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up